Viking Therapeutics, Inc.VKTXNASDAQ
LOADING
|||
Net Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-109.96M
↓ 136% below average
Average (9y)
$-46.58M
Historical baseline
Range
High:$-14.73M
Low:$-109.96M
CAGR
+18.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-109.96M | -28.0% |
| 2023 | $-85.89M | -24.7% |
| 2022 | $-68.87M | -25.2% |
| 2021 | $-54.99M | -39.2% |
| 2020 | $-39.49M | -53.2% |
| 2019 | $-25.78M | -16.8% |
| 2018 | $-22.06M | -7.2% |
| 2017 | $-20.58M | -39.7% |
| 2016 | $-14.73M | +37.1% |
| 2015 | $-23.40M | - |